ATE15596T1 - Pharmazeutische mittel. - Google Patents

Pharmazeutische mittel.

Info

Publication number
ATE15596T1
ATE15596T1 AT81301734T AT81301734T ATE15596T1 AT E15596 T1 ATE15596 T1 AT E15596T1 AT 81301734 T AT81301734 T AT 81301734T AT 81301734 T AT81301734 T AT 81301734T AT E15596 T1 ATE15596 T1 AT E15596T1
Authority
AT
Austria
Prior art keywords
sub
methyl group
pharmaceutical agent
hydrogen atom
composition
Prior art date
Application number
AT81301734T
Other languages
English (en)
Inventor
David John Gilbert
Derek Andrew Hollingsbee
Original Assignee
Smith & Nephew Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith & Nephew Ass filed Critical Smith & Nephew Ass
Application granted granted Critical
Publication of ATE15596T1 publication Critical patent/ATE15596T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
AT81301734T 1980-04-18 1981-04-21 Pharmazeutische mittel. ATE15596T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8012853 1980-04-18
EP81301734A EP0038698B1 (de) 1980-04-18 1981-04-21 Pharmazeutische Mittel

Publications (1)

Publication Number Publication Date
ATE15596T1 true ATE15596T1 (de) 1985-10-15

Family

ID=10512870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81301734T ATE15596T1 (de) 1980-04-18 1981-04-21 Pharmazeutische mittel.

Country Status (11)

Country Link
US (2) US4349563A (de)
EP (1) EP0038698B1 (de)
JP (1) JPS56166114A (de)
AT (1) ATE15596T1 (de)
AU (1) AU6947781A (de)
CA (1) CA1171790A (de)
DE (1) DE3172298D1 (de)
GB (1) GB2075341B (de)
IE (1) IE51085B1 (de)
NZ (1) NZ196700A (de)
ZA (1) ZA812262B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77022C (fi) * 1981-08-10 1989-01-10 Merck & Co Inc Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrrolaettiksyraderivat.
US4423060A (en) * 1981-08-17 1983-12-27 Ayerst, Mckenna & Harrison Inc. Aldose reductase inhibition by 1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
FR2641464B1 (fr) * 1989-01-06 1994-06-03 Rolland Sa A Nouvelles compositions pharmaceutiques manifestant des proprietes inhibitrices vis-a-vis de la phospholipase a2
DE69504489T2 (de) * 1994-04-07 1999-05-20 The Procter & Gamble Co., Cincinnati, Ohio Bleichmittel enthaltend metall haltige bleichkatalysatoren und antioxidantien
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
DE69937549T2 (de) 1998-03-11 2008-09-04 Warner-Lambert Company Llc Polyvinylalkohol-zusammensetzungen
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
US6479060B1 (en) 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE602004023921D1 (de) 2003-03-10 2009-12-17 Nycomed Gmbh Neues verfahren zur herstellung vonroflumilast
USD516425S1 (en) 2004-10-27 2006-03-07 Owens- Illinois Closure Inc. Dispensing closure
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
US20070259021A1 (en) * 2006-05-01 2007-11-08 Friedlaender Mitchell H Compositions, Methods, and Kits for Treating Dry Eye
US10357470B2 (en) * 2013-03-07 2019-07-23 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
US9241971B1 (en) 2014-07-18 2016-01-26 Kurobe, Llc Topical vancomycin formulation and methods of use
CA2974220C (en) * 2015-02-06 2023-05-16 Latitude Pharmaceuticals, Inc. Aqueous solution formulations of vancomycin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752826A (en) * 1970-01-26 1973-08-14 Mcneilab Inc Aroyl substituted pyrroles
CA1083044A (en) * 1976-05-04 1980-08-05 Stewart Wong Antiarthritic potentiation
US4152430A (en) * 1977-09-22 1979-05-01 William H. Rorer, Inc. Synergistic compositions and method of use

Also Published As

Publication number Publication date
ZA812262B (en) 1982-04-28
AU6947781A (en) 1981-10-22
EP0038698A3 (en) 1982-10-27
IE810785L (en) 1981-10-18
DE3172298D1 (en) 1985-10-24
GB2075341A (en) 1981-11-18
JPS56166114A (en) 1981-12-21
CA1171790A (en) 1984-07-31
US4349563A (en) 1982-09-14
US4421741A (en) 1983-12-20
EP0038698A2 (de) 1981-10-28
EP0038698B1 (de) 1985-09-18
NZ196700A (en) 1983-04-12
GB2075341B (en) 1983-12-14
IE51085B1 (en) 1986-10-01

Similar Documents

Publication Publication Date Title
ATE15596T1 (de) Pharmazeutische mittel.
SE9604786D0 (sv) New compounds
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
SE9504661D0 (sv) New compounds
DK0532862T3 (da) Anvendelse af rapamycin til fremstilling af et lægemiddel til behandling af øjeninflammation
EP0382066A3 (de) Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
ES2063073T3 (es) Derivados de arilmetilenilo conocidos y nuevos seleccionados de tiazolidinonas, imidazolidinonas y oxazolidinonas utiles como agentes antialergicos y agentes antiinflamatorios.
MX9102209A (es) Derivados de acido hidroxamico y n-hidroxiurea novedosos y su uso.
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
NO307687B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av neuro-AIDS
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
RU94045866A (ru) Применение бисфенилалкилпиперазинов для лечения расстройств, вызванных злоупотреблением веществами, способ лечения
KR950016760A (ko) 치질 치료제
CA2417935A1 (en) Anti-inflammatory medicament
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
IE45200L (en) Pharmaceutical composition
ATE44461T1 (de) Analgetische zusammensetzungen.
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties